The discovery of secondary sigma factors in Bacillus subtilis that enable RNA polymerase to transcribe cloned sporulation genes in vitro has led to the proposal that the appearance of new sigma factors during sporulation directs RNA polymerase to the different temporal classes of sporulation genes. One sigma factor, which appears 2 h after the initiation of sporulation, is crE (formerly (729). Mutations that inactivate the structural gene for aE prevent transcription from promoter G4. To determine whether (E-RNA polymerase interacts with the G4 promoter in vivo, we examined the effects of six single-base-pair substitutions in the G4 promoter on its utilization in vivo and in vitro by rE-RNA polymerase. The mutations in the G4 promoter affected utilization of the promoter in vivo in the same way that they affected its utilization in vitro by purified &e-RNA polymerase; therefore, we conclude that this polymerase interacts directly with the G4 promoter in vivo. The effects of these mutations also support the model in which (E-RNA polymerase utilizes promoters by interacting with two distinct sets of nucleotides located 10 and 35 base pairs upstream from the start point of transcription.
In response to nutrient depletion, the gram-positive bacterium Bacillus subtilis can differentiate into a dormant endospore (for a review, see reference 5). This differentiation requires the products of approximately 100 sporulationspecific genes, and transcription of these genes appears to be activated in a precise temporal sequence. The discovery of secondary sigma factors from B. subtilis that can direct RNA polymerase to transcribe cloned sporulation genes in vitro has led to the proposal that the appearance of new sigma factors during sporulation redirects the RNA polymerase to transcribe the different temporal classes of sporulation genes.
The association of a sigma factor with the core moiety of RNA polymerase (subunits 1313'a2) enables the holoenzyme to bind to promoters and thus to efficiently initiate transcription. The six different sigma factors that have been isolated from B. subtilis were discovered because they enable RNA polymerase to efficiently use a specific promoter in an in vitro transcription reaction. Recently, some progress has been made for assessing the role of these sigma factors in vivo. For example, sigB, the structural gene for cB (formerly c37) has been identified and cloned (1) . RNA polymerase containing a& (Eo-3) will utilize the ctc promoter and the spoVG P1 promoter in an in vitro transcription reaction. Inactivation of sigB prevents transcription of ctc in vivo (1) but does not affect spoVG transcription (M. Lampe, M. Igo, W. Schaffer, C. Binnie, R. Losick, C. Ray, and C. P. Moran, Jr., in W. S. Reznikoff, R. Burgess, J. Dulberg, C. Gross, T. Record, and M. Whicker, ed., RNA Polymerase and the Regulation of Transcription, in press). Another sigma factor, &r3O, probably accounts for most of the transcription from the spoVG P1 promoter (3); however, only a thorough genetic analysis will enable us to assess the role of each sigma factor in vivo.
Two hours after the initiation of sporulation, a new sigma factor, cE (formerly n29), appears (4) . This is the product of the gene sigE in the spoIlIG operon (11) . Because mutations in sigE prevent sporulation, the product of this gene is * Corresponding author. essential for sporulation, and the sigma activity of this gene product is presumed to be the essential function. In one model, the appearance of this sigma factor activates transcription of several genes. Mutations in sigE have been shown to prevent transcription from several promoters, including spoIID (9) and G4 (8) . Because these promoters are used by EaE during an in vitro transcription assay, it is also likely that EaE utilizes them in vivo. In this model, mutations in sigE that inactivate aE prevent transcription from promoters such as spoIID and G4 because no other form of RNA polymerase in B. subtilis can utilize these promoters. In an alternative model, the mutations in sigE may prevent the expression of another gene product that is required for the use of the G4 and spolID promoters in vivo. In this model, the sigE gene product does not directly interact with these promoters. We have examined the effects of mutations in the G4 promoter on its utilization in vivo and in vitro by EarE, and the results of our study support the model in which cE directly interacts with the G4 promoter in vivo. Moreover, the mutations identify nucleotides in the G4 promoter that signal recognition of this promoter by EoE.
MATERIALS AND METHODS RNA synthesis. cE RNA polymerase from B. subtilis SMY was purified by gradient elution from DNA-cellulose as previously described (10) .
The protocol for the prebinding transcriptions has also been described previously (10) . EaE was incubated at 37°C for 10 min with 2 ,g of DNA template (unless otherwise indicated) in a 40-,u reaction. In each reaction, the DNA template had been cleaved at a unique site downstream from the G4 promoter. RNA synthesis was initiated by the addition of 65 ,uM ATP, GTP, and CTP and 0.5 ,uM (10 , uCi) [a-32P]UTP. After 1 min, heparin (6 ,g) was added to prevent reinitiation. The mixture was incubated for an additional 10 min at 37°C, and unlabeled UTP (65 ,M) was added. After an additional 5 min of incubation, the reaction was stopped by the addition of an equal volume of stop mix (10 M Haldenwang. Plasmid pLC1 has been described previously (7) . Plasmids were amplified in E. coli HB101, and plasmid DNA was prepared by alkaline lysis followed by centrifugation in cesium chloride-ethiditim bromide density gradients (2) . Restriction endonucleases were obtained from Amersham Corp. and were used as recommended by the supplier. Oligonucleotide-directed mutagenesis. Base substitutions in the G4 promoter were constructed by using the oligonucleotide-directed mutagenesis procedure of Zoller and Smith (13) . The cloning of the wild-type G4 promoter between the PstI and SmaI restriction sites of M13mpl9 and the construction of mutant G4 promoters G4-1, G4-2, and G4-3 have been described previouisly' (6) . Three additional mutant 04 promoters, G4-4', G4-5, and G4-6, were made by using mutagenic oligonucleotides. The conditions for the annealing reactions, for the formation of the' double-stranded heteroduplexes, and for the enrichment of covalently closed circular DNA by using S1 nuclease were as described previously (6) . After transfection into E. coli 71.18 and plating, the plaques were screened by hybridization with a radiolabeled mutagenic oligonucleotide (13) . Phage DNA from each positive plaque was sequenced by the dideoxy chain termination method.
The PstI-SacI DNA fragment containing each of the six mutated G4 promoters in M13mpl9 was excised and recloned between the PstI-SacI sites in plasmlid pUC19 and was subsequently transformed into E. coli TB1. The nucleotide sequence of the PstI-SacI DNA fragments which contained the mutant G4 promoters in each plasmid was determined by the dideoxy chain termination procedure with linearized double-stranded DNA and universal primer (1211; New England BioLabs). Transformations were performed as described previously (7) .
Construction of G4-xylE fusion plasmids. As described above, the wild-type and mutant G4 promoters were cloned into pUC19 and M13mpl9. The G4 promoters of these clones were excised as HindIII-KpnI fragments and were ligated to HindIII-KpnI-digested pLC1 (7 harvested and washed, and extracts were prepared as described previously (7). Catechol 2,3-dioxygenase (CatO2ase) activities were determined in a 3-ml volume that contained 1 ml of extract, 2 ml of 100 mM potassium phosphate (pH 7.5), and 67 ,uM catechol. Protein concentrations were measured by assay (Bio-Rad Laboratories) with bovine serum albumin as the standard (7).
Assay of CAT. Samples (15 ml) were removed from the cultures that had been used for assaying CatO2ase activities. The cells were centrifuged, and the pellets were washed with 3 ml of 50 mM Tris-1 M NaCl (pH 8.0). The pellets were frozen overnight at -20°C, and extracts were prepared by the method of Truitt et al. (12) . Chloramphenicol acetyl conserved among promoters that are utilized in vitro by E&e (6) . The single-base substitutions in mutant promoters G4-1, G4-2, G4-3, G4-4, G4-5, and G4-6 are labeled 1, 2, 3, 4, 5, and 6, respectively. transferase (CAT) activity was measured spectrophotometrically (12) at 37°C in a total volume of 3 ml which contained 10 ,u of extract, 100 mM Tris (pH 8.0), 0.1 mM acetyl coenzyme A, 1 (6) . We now refer to these mutant promoters as G4-1, G4-2, and G4-3 ( Fig. 1) . We have used oligonucleotide-directed mutagenesis to construct three additional mutant G4 promoters, G4-4, G4-5, and G4-6, that have single-base substitutions (Fig. 1) . The PstI-SacI DNA fragments that contained the mutant promoters G4-4, G4-5, and G4-6 were removed from M13mpl9, in which they had been isolated originally (see Materials and Methods), and were recloned between the PstI and SacI restriction sites of pUC19. The nucleotide sequences of the PstI-SacI DNA fragments that contained the mutant promoters in each plasmid were determined and were found to contain only the desired single-base substitutions. The wild-type promoter and the mutant promoters 64-1, G4-2, and G4-3 had been cloned previously into pUC19 (6) (Fig. 2, lane o) and a 115-nucleotide runoff transcript when the template had been cleaved with EcoRI (Fig. 2, lane n) . As noted in our previous report (6), a 55-nucleotide transcript was also seen. It was probably the product of premature termination of transcription from the G4 promoter, rather than a runoff transcript, since it was present when the G4 promoter was utilized, regardless of where the template had been cleaved before transcription. When the two linear templates containing the wild-type G4 promoter, one cleaved at the EcoRI site and the other cleaved at the PvuII site downstream from the promoter, were mixed, equal amounts of the 115-and 205-nucleotide transcripts were generated (Fig. 2, lane p) . As expected, the two wild-type promoters appeared to compete equally well for the available EaE in the reaction. The templates containing the mutant G4 promoters were cleaved with PvuII and used in similar in vitro transcription reactions with Ea E (Fig.  2) . The 205-nucleotide runoff transcript was produced in each case. Each of these PvuII-cleaved templates also was mixed with an equimolar amount of the EcoRI-cleaved template that contained the wild-type promoter. Densitometric tracings of the autoradiographs from two experiments like the one shown in Fig. 2 were used to quantitate the ratio of the transcripts from the mutant and wild-type promoters in each reaction. Promoters G4-1 and G4-5 were least able to direct transcription in vitro by EurE (Fig. 2, lanes b and j) . Promoters G4-1 and G4-5 produced only 5 and 3%, respectively, of the amount of transcripts produced by the wildtype promoter in the same reaction. Because the addition of the G4-1 and G4-5 templates to the wild-type promoter template did not reduce transcription from the wild-type promoter (Fig. 2, lanes b and j) , the inefficiency of utilization of these mutant templates by EcrE was not due to the presence of an inhibitor in the mutant template preparation. Moreover, transcripts from plasmid-encoded promoters were generated in vitro by E. coli RNA polymerase equally well from all of the templates; therefore, the G4-5 template had not suffered nonspecific damage that decreased its use as a transcription template (data not shown). We concluded that the inefficiency of utilization of promoters G4-1 and G4-5 by Ec.E was due to the single-base substitutions in these promoters.
Promoters G4-2, G4-3, and G4-4 appeared to be used at intermediate levels. The mutations in these promoters did not produce any drastic effects, but these mutant promoters reproducibly competed less efficiently for EuE than did the wild-type promoter (Fig. 2, lanes d, f, and h ), producing 38, 26, and 39%, respectively, of the amount of transcripts produced by the wild-type promoter in the same reaction. Promoter G4-6 directed transcription by EcE almost as efficiently (55%) as the wild-type promoter did in the competition reaction with the wild-type promoter and in a reaction where it was the only template present (Fig. 2.,  lanes 1 and m, respectively) . In a reciprocal set of experiments, the wild-type promoter template that had been cut with PvuII was used in a competition reaction against the mutant templates that had been cut so that transcription from the mutant templates generated shorter transcripts. These experiments confirmed our analysis of the relative efficiencies of the mutant promoters.
G4-directed expression of xylE. The activities of the wildtype and mutant G4 promoters were monitored in vivo by using these promoters to direct expression of a promoterless derivative of the xylE gene from Pseudomonas putida. The G4 promoter and each mutated derivative was excised from the pUC19 derivative and cloned between the HindIII and KpnI restriction sites of pLCl as described in Materials and Methods. These promoters are oriented such that they direct transcription through xylE, which encodes the ribosomebinding site, the start codon, and the structural gene for CatO2ase. The pLCl derivatives were isolated in E. coli and were then transformed into B. subtilis, in which the transformants were selected by their resistance to chloramphenicol. The synthesis of CatO2ase by a transformant was monitored at 1-h intervals after inoculation into Difco sporulation medium. The specific activity of CatO2ase in B. subtilis JH642 containing plasmid pCRGO, the pLCl derivative with the wild-type G4 promoter, increased rapidly from 2 to 4 h after the cells entered stationary phase and began endospore formation (Fig. 3) . B. subtilis containing pLCl produced a small amount of CatO2ase during exponential growth, but this amount of CatO2ase decreased after the cells entered stationary phase (Fig. 3) . We concluded that CatO2ase expression by pCRGO depended on the HindIIIKpnI DNA fragment that contained the G4 promoter. Transcription from the G4 promoter in vivo has been shown to depend on the expression of spoIIG, the structural gene for oa29 (8) . To demonstrate that CatO2ase expression was directed by the G4 promoter on the HindIII-KpnI DNA fragment of pCRGO, we assayed CatO2ase expression from pCRGO in strain BS50, which has an inactive allele of spolIG. This strain failed to express CatO2ase (Table 1) ; therefore, we concluded that the G4 promoter of pCRG0 directed transcription of xylE.
Effects of mutations on xylE expression. The synthesis of CatO2ase directed by each of the mutant promoters was monitored as described above for pCRGO. The effects of the mutations can be divided into three classes. The plasmids with mutant promoters G4-1 and G4-5 (pCRG1 and pCRG5, respectively) expressed little or no CatO2ase; plasmid pCRG6 caused levels of expression of CatO2ase similar to levels seen with the wild-type promoter, whereas plasmids pCRG2, pCRG3, and pCRG4 produced CatO2ase at intermediate rates (Table 1) . If the mutations in the plasmids affected CatO2ase expression by changing the copy number or some other state of the plasmid, then we would have expected to find that the amount of the plasmid-encoded CAT would have varied directly with the amount of CatO2ase produced by each plasmid. The specific activity of CAT produced by the strains that contained the various plasmids did not differ Figure 1 shows the nucleotide sequences conserved among promoters that are used in vitro by ErE. It was shown previously that mutations in the ctc promoter at the -10 and -35 regions affect utilization of that promoter in vitro by EcrE, whereas base substitutions at other positions in the promoter have no effect (10) . Rather et al. (6) found that three single-base-pair substitutions in the G4 promoter that changed highly conserved nucleotides (Fig. 1, mutations 1 , 2, and 3) reduced utilization of the promoter in vitro by E&rE. We constructed three additional single-base substitutions and tested the effects of these substitutions on the use of the promoter in vitro by EaE. Of those tested, the nucleotides at positions -7 and -11 appear to be the most important for utilization of this promoter by EcE. The substitutions at positions -14 and -35 caused definite but less severe effects, leading us to conclude that these positions are also important for the use of this promoter by Eo.E. Mutation 6 (Fig. 1) , which produced a more consensuslike sequence at position -30, had little effect. This finding may be explained by the fact that the base pair at this position is not very important in the context of this very efficient promoter. These results support the model in which distinct nucleotide sequences at two regions of the promoter (10 and 35 base pairs upstream from the start point of transcription) signal utilization of the promoter by EcrE.
We also have examined the function of the G4 promoter in vivo by fusing it to xylE of plasmid pLC1. Several lines of evidence indicate that transcription ofxylE in the strains was initiated at the G4 promoter. In cells containing the plasmid without the G4 promoter, xylE was not efficiently expressed.
In cells containing the plasmid with the G4 promoter (pCRG0), synthesis of the xylE gene product (CatO2ase) began about 2 h after the end of exponential growth, which is the same time that transcription normally begins for the G4 promoter in the chromosome (8) . Moreover, transcription from the G4 promoter in the chromosome is prevented by a mutation in spoIIG (8) , and this mutation prevented expression ofxylE on plasmid pCRGO. Finally, mutations in the G4 promoter prevented expression of xylE (see below); therefore, xylE expression was dependent on transcription initiated at the G4 promoter.
We examined the effects of base substitutions in the G4
promoter on expression of xylE by constructing a series of plasmids that were homologous to pCRGO except for different single-base-pair substitutions in the G4 promoter. The effects of the base substitutions were specific to xylE synthesis and did not have a more general effect on expression of plasmid-encoded genes, since the level of expression of another plasmid-encoded gene, that for CAT, was not affected by the mutations. The mutations, therefore, specifically affected G4 promoter activity. The G4 promoter is used efficiently in vitro by purified EoE; therefore, this polymerase may be capable of utilizing this promoter in vivo. Si nuclease mapping experiments demonstrated that transcription from the G4 promoter in vivo is activated about 2 h after the initiation of sporulation (8), which is the time at which 0.E is produced, and transcription from this promoter is not observed in a strain that has a defective allele of the structural gene for cE (8) . Therefore, uE is essential for transcription from the G4 promoter in vivo and could interact directly with the promoter or could work indirectly by directing the transcription of another gene product that is essential for G4 transcription. The model in which oE interacts directly with the G4 promoter is supported by our observations that single-base substitutions in the G4 promoter affect utilization of the promoter in vivo in the same way that they affect utilization of the promoter in vitro by purified EaE (i.e., mutated promoters that are used less efficiently than is the wild-type promoter by EaE in vitro also are used less efficiently in vivo, and mutant promoters that are used efficiently in vitro also are used efficiently in vivo). It is not surprising that the mutations had slightly different quantitative effects in vivo and in vitro since linear templates were used in the in vitro assays and supercoiled plasmids carried the promoters in vivo. Despite these and other problems associated with the quantitation of promoter activity, there was a remarkably good correlation of promoter activity in vivo and in vitro.
In light of the surprising observation that transcription in vivo of spoVG is not dependent on aB (formerly o37) (Lampe et al. in press), even though in vitro transcription of spoVG had led to the discovery of this sigma factor, several criteria must be satisfied to clearly establish that a specific form of RNA polymerase utilizes a promoter in vivo. The polymerase should be shown to utilize the promoter in vitro, and transcription from the promoter in vivo should occur during that part of the life cycle of the bacterium when the sigma factor is known to be active. Inactivation of the gene encoding the sigma factor can be used to demonstrate that the sigma factor is essential for utilization of the promoter, and mutations in the promoter that prevent its utilization in vitro by the purified RNA polymerase should reduce its utilization in vivo. These criteria seem to have been satisfied in the case of utilization of the ctc promoter by ErB (1, 7) and now in the utilization of the G4 promoter by EcrE. It should be noted, however, that we have examined the effects of only six mutations in the G4 promoter; therefore, it is possible that examination of additional mutations in this promoter may lead us to modify our model in which G4 is used exclusively by Eo-E. The finding of a mutant with an altered sigma factor that is able to suppress the effect of a promoter mutation in an allele-specific interaction would provide final compelling evidence that the sigma factor directly interacts with the promoter. This type of mutant has not been described thus far for any bacterial system, but the mutant G4 promoters that we have described here may serve as useful tools for the analysis of mutant forms of oE.
